 | • レポートコード：MRC2301H119 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、232ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料では、2021年に2,238.64百万ドルであった世界の前臨床イメージング市場規模が、2022年に2,378.54百万ドルになり、2027年まで年平均6.42%で成長して3,252.95百万ドルに拡大すると予測しています。本資料は、前臨床イメージングの世界市場について調べ、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（モダリティ、試薬）分析、用途別（創薬、研究開発）分析、エンドユーザー別（バイオテクノロジー企業、製薬会社、研究所）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目を掲載しています。また、Angstrom Advanced Inc、Aspect Imaging Ltd、Berthold Technologies、Bruker Corporation、Capintec, Inc、Faxitron Bioptics, LLC、FUJIFILM Holdings America Corporationなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の前臨床イメージング市場規模：製品別 - モダリティの市場規模 - 試薬の市場規模 ・世界の前臨床イメージング市場規模：用途別 - 創薬における市場規模 - 研究開発における市場規模 ・世界の前臨床イメージング市場規模：エンドユーザー別 - バイオテクノロジー企業における市場規模 - 製薬会社における市場規模 - 研究所における市場規模 ・世界の前臨床イメージング市場規模：地域別 - 南北アメリカの前臨床イメージング市場規模 アメリカの前臨床イメージング市場規模 カナダの前臨床イメージング市場規模 ブラジルの前臨床イメージング市場規模 … - アジア太平洋の前臨床イメージング市場規模 日本の前臨床イメージング市場規模 中国の前臨床イメージング市場規模 インドの前臨床イメージング市場規模 韓国の前臨床イメージング市場規模 台湾の前臨床イメージング市場規模 … - ヨーロッパ/中東/アフリカの前臨床イメージング市場規模 イギリスの前臨床イメージング市場規模 ドイツの前臨床イメージング市場規模 フランスの前臨床イメージング市場規模 ロシアの前臨床イメージング市場規模 … - その他地域の前臨床イメージング市場規模 ・競争状況 ・企業情報 |
The Global Preclinical Imaging Market size was estimated at USD 2,238.64 million in 2021 and expected to reach USD 2,378.54 million in 2022, and is projected to grow at a CAGR 6.42% to reach USD 3,252.95 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Preclinical Imaging to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Modalities and Reagents. The Modalities is further studied across Magnetic Particle Imaging, Magnetic Resonance Imaging, Micro-computed Tomography, Optical Imaging, Positron Emission Tomography, and Single-photon Emission Computed Tomography. The Reagents is further studied across Bioluminescent Imaging Reagents, Fluorescent Imaging Reagents, MRI Contrasting Reagents, PET Radioactive Tracers, Ultrasound Contrasting Reagents, and X-ray CT Contrasting Reagents.
Based on Application, the market was studied across Drug Discovery and Research and Development.
Based on End-User, the market was studied across Biotech Companies, Pharmaceutical Companies, and Research Institutes.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Preclinical Imaging market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Preclinical Imaging Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Preclinical Imaging Market, including Angstrom Advanced Inc, Aspect Imaging Ltd, Berthold Technologies, Bruker Corporation, Capintec, Inc, Faxitron Bioptics, LLC, FUJIFILM Holdings America Corporation, General Electric (GE), Hamamatsu Photonics K.K., Hitachi Medical Corporation, INDEC BioSystems, Koninklijke Philips N.V., KUB Technologies, Li-Cor Biosciences, Mediso Ltd, MILabs B.V, Miltenyi Biotec GmbH, MR Solutions Group, Naviscan, Inc., Northridge Tri-Modality Imaging, Inc, Peira bvba, PerkinElmer Inc, SciTech Pty Ltd, Siemens A.G, and Thermo Fisher Scientific.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Preclinical Imaging Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Preclinical Imaging Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Preclinical Imaging Market?
4. What is the competitive strategic window for opportunities in the Global Preclinical Imaging Market?
5. What are the technology trends and regulatory frameworks in the Global Preclinical Imaging Market?
6. What is the market share of the leading vendors in the Global Preclinical Imaging Market?
7. What modes and strategic moves are considered suitable for entering the Global Preclinical Imaging Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing adaptation of diagnostic imaging
5.1.1.2. Rising demand for non-invasive diagnostics and therapeutic devices
5.1.1.3. Growing number of clinical research organizations (CROs) and pharmaceutical companies
5.1.2. Restraints
5.1.2.1. Lack of reimbursement coverage
5.1.3. Opportunities
5.1.3.1. Technological advancements in molecular imaging
5.1.3.2. Increase in preclinical research funding, by both private and public organizations
5.1.4. Challenges
5.1.4.1. Strict regulatory framework preclinical research
5.2. Cumulative Impact of COVID-19
6. Preclinical Imaging Market, by Product
6.1. Introduction
6.2. Modalities
6.3.1. Magnetic Particle Imaging
6.3.2. Magnetic Resonance Imaging
6.3.3. Micro-computed Tomography
6.3.4. Optical Imaging
6.3.5. Positron Emission Tomography
6.3.6. Single-photon Emission Computed Tomography
6.3. Reagents
6.4.1. Bioluminescent Imaging Reagents
6.4.2. Fluorescent Imaging Reagents
6.4.3. MRI Contrasting Reagents
6.4.4. PET Radioactive Tracers
6.4.5. Ultrasound Contrasting Reagents
6.4.6. X-ray CT Contrasting Reagents
7. Preclinical Imaging Market, by Application
7.1. Introduction
7.2. Drug Discovery
7.3. Research and Development
8. Preclinical Imaging Market, by End-User
8.1. Introduction
8.2. Biotech Companies
8.3. Pharmaceutical Companies
8.4. Research Institutes
9. Americas Preclinical Imaging Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Preclinical Imaging Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Preclinical Imaging Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Angstrom Advanced Inc
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Aspect Imaging Ltd
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Berthold Technologies
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Bruker Corporation
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Capintec, Inc
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Faxitron Bioptics, LLC
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. FUJIFILM Holdings America Corporation
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. General Electric (GE)
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Hamamatsu Photonics K.K.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Hitachi Medical Corporation
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. INDEC BioSystems
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Koninklijke Philips N.V.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. KUB Technologies
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Li-Cor Biosciences
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Mediso Ltd
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. MILabs B.V
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Miltenyi Biotec GmbH
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. MR Solutions Group
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Naviscan, Inc.
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Northridge Tri-Modality Imaging, Inc
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Peira bvba
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. PerkinElmer Inc
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. SciTech Pty Ltd
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Siemens A.G
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. Thermo Fisher Scientific
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing